
Holcim has signed an agreement to acquire Duro-Last, a US-based leader in commercial roofing systems. Duro-Last’s systems range from cool roofs, enhancing buildings’ energy efficiency, to its award-winning ‘Recycle Your Roof’ programme, driving circularity in roofing. It is also the first company in the US to offer third-party verified environmental product declarations for its thermoplastic roofing solutions.
According to Holcim, with Dura-Last’s track record of double-digit growth in North America’s over US$40bn roofing market, its systems will complement and strengthen Holcim’s integrated roofing offer, with expected synergies of US$60m each year.
Related: Brazil Watchdog Greenlights Sale Of Holcim’s Local Business
“I’m excited to welcome Duro-Last into Holcim’s broad range of innovative and sustainable building solutions. Duro-Last is a perfect strategic fit for our roofing business. Its proprietary technologies and leading brands complement our offering in the fast-growing North American market. Its energy-efficient systems and excellence in recycling will further advance our leadership in sustainability,” said Jan Jenisch, CEO, Holcim.
This acquisition advances Holcim’s ‘Strategy 2025 – Accelerating Green Growth’ with the goal to expand its Solutions & Products business to 30 percent of group net sales by 2025, entering the most attractive construction segments, from roofing and insulation to repair and refurbishment. The transaction, which has been valued at US$1293m, is expected to close by the 2Q23.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas